Fortrea Holdings (FTRE) Share-based Compensation (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Share-based Compensation came in at $12.6 million in Q2 2026, down 44.49% on a YoY basis from $22.7 million in Q2 2025, and up 10.53% quarter-over-quarter from $11.4 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Share-based Compensation (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Share-based Compensation for 5 consecutive years, with $12.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation fell 44.49% year-over-year to $12.6 million; the trailing twelve-month figure through Jun 2026 stood at $61.1 million (down 6.86% YoY), and the FY2025 full-year result was $74.4 million, up 27.4% from the prior year.
- Share-based Compensation rose to $12.6 million in Q2 2026 per FTRE's latest filing, from $11.4 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $22.7 million in Q2 2025 and bottomed at $5.8 million in Q4 2022.
- Historically, Share-based Compensation has averaged $13.2 million across 5 years, with a median of $13.8 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Share-based Compensation surged 167.24% in 2023, then slumped 44.49% in 2026.
- Over 5 years, Share-based Compensation stood at $5.8 million in 2022, then soared by 167.24% to $15.5 million in 2023, then retreated by 1.29% to $15.3 million in 2024, then dropped by 3.27% to $14.8 million in 2025, then slipped by 14.86% to $12.6 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $12.6 million, $11.4 million, and $14.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 95.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 4.35 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 19.78 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 18.46 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 12.60 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 7.60 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 357,000.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 590,899.88 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.60 Mn |
| Mar 31, 2026 | 11.40 Mn |
| Dec 31, 2025 | 14.80 Mn |
| Sep 30, 2025 | 22.30 Mn |
| Jun 30, 2025 | 22.70 Mn |
| Mar 31, 2025 | 14.60 Mn |
| Dec 31, 2024 | 15.30 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.10 Mn |
| Dec 31, 2023 | 15.50 Mn |
| Sep 30, 2023 | 11.10 Mn |
| Jun 30, 2023 | 9.40 Mn |
| Mar 31, 2023 | 6.70 Mn |
| Dec 31, 2022 | 5.80 Mn |
| Sep 30, 2022 | 6.40 Mn |